18 Members•4,119 Posts

Pharma & Biotech

Poolbeg Pharma: Sites ready, data due this summer — and Big Pharma is starting to knock

Apr 28, 2026

Stephen Gunnion

Santhera reconfirms cash flow breakeven target as AGAMREE revenues near-double

Apr 28, 2026

Ian Lyall

Poolbeg Pharma eyes partnering deals as cancer immunotherapy trial heads for summer data

Apr 28, 2026

Ian Lyall

Scancell wins FDA fast-track status for melanoma immunotherapy

Apr 28, 2026

Ian Lyall

Orthocell's Remplir hits 90% success rate

Apr 28, 2026

Kerry Stevenson

GLP-1 pill race heats up as Wegovy tablet holds strong against Lilly rival

Apr 27, 2026

Ian Lyall

Citi sees Daiichi supply review as immaterial for AstraZeneca

Apr 27, 2026

Ian Lyall

Serval Resources: From Aquis to AIM — and targeting $1B in Africa's hottest copper belts

Apr 27, 2026

Stephen Gunnion

Paradigm Biopharmaceuticals raises $14M in upsized placement, launches SPP

Apr 27, 2026

Jonathan Jackson

BioVie to host KOL event highlighting Bezisterim's potential in Parkinson's Disease

Apr 27, 2026

Angela Harmantas

Oscillate, Bango, AOTI, EnergyPathways, 88 Energy, Powerhouse Energy - Small Cap Snapshot

Apr 27, 2026

Stephen Gunnion

Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin syndrome

Apr 27, 2026

Angela Harmantas

AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials

Apr 27, 2026

Angela Harmantas

GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio

Apr 27, 2026

Ian Lyall

Santhera wins backing to extend DMD drug AGAMREE to toddlers as young as two

Apr 27, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy